1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Bioproduction Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Bioproduction Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Bioproduction Market Regional Analysis
6.2 North America Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 North America Bioproduction Market Forecast Analysis
7. North America Bioproduction Market Analysis – by Product
7.1 Biologics and Biosimilars
- 7.1.1 Overview
- 7.1.2 Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Vaccines
- 7.2.1 Overview
- 7.2.2 Vaccines: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Cell and Gene Therapies
- 7.3.1 Overview
- 7.3.2 Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Nucleic Acid Therapeutics
- 7.4.1 Overview
- 7.4.2 Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Bioproduction Market Analysis – by Application
8.1 Rheumatoid Arthritis
- 8.1.1 Overview
- 8.1.2 Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Hematological Disorders
- 8.2.1 Overview
- 8.2.2 Hematological Disorders: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Cardiovascular Diseases
- 8.5.1 Overview
- 8.5.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Bioproduction Market Analysis – by Equipment
9.1 Upstream Equipment
- 9.1.1 Overview
- 9.1.2 Upstream Equipment: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Downstream Equipment
- 9.2.1 Overview
- 9.2.2 Downstream Equipment: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Bioreactors
- 9.3.1 Overview
- 9.3.2 Bioreactors: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Consumables and Accessories
- 9.4.1 Overview
- 9.4.2 Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Bioproduction Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Contract Manufacturing Organizations
- 10.2.1 Overview
- 10.2.2 Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. North America Bioproduction Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Bioproduction Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 North America Bioproduction Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 US: North America Bioproduction Market Breakdown, by Product
- 11.2.1.1.2 US: North America Bioproduction Market Breakdown, by Application
- 11.2.1.1.3 US: North America Bioproduction Market Breakdown, by Equipment
- 11.2.1.1.4 US: North America Bioproduction Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Canada: North America Bioproduction Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America Bioproduction Market Breakdown, by Application
- 11.2.1.2.3 Canada: North America Bioproduction Market Breakdown, by Equipment
- 11.2.1.2.4 Canada: North America Bioproduction Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Mexico : North America Bioproduction Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America Bioproduction Market Breakdown, by Application
- 11.2.1.3.3 Mexico : North America Bioproduction Market Breakdown, by Equipment
- 11.2.1.3.4 Mexico : North America Bioproduction Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Bio-Rad Laboratories Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Danaher Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Lonza Group AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Merck KGaA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Sartorius AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Thermo Fisher Scientific Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations